BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SM, Kim HS, Lee S, Lee JW. Emerging role of 18F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma. World J Gastroenterol 2019; 25(11): 1289-1306 [PMID: 30918424 DOI: 10.3748/wjg.v25.i11.1289] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, Wang SB. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2019; 25(32): 4682-4695 [PMID: 31528094 DOI: 10.3748/wjg.v25.i32.4682] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
2 Geist BK, Wang J, Wang X, Lin J, Yang X, Zhang H, Li F, Zhao H, Hacker M, Huo L, Li X. Comparison of different kinetic models for dynamic 18 F-FDG PET/CT imaging of hepatocellular carcinoma with various, also dual-blood input function. Phys Med Biol 2020;65:045001. [DOI: 10.1088/1361-6560/ab66e3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lin BQ, Zhang WB, Zhao J, Zhou XH, Li YJ, Deng J, Zhao Q, Fu G, Xie CM, Xu YK, Feng GK. An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice. J Hepatocell Carcinoma 2021;8:645-56. [PMID: 34235103 DOI: 10.2147/JHC.S312921] [Reference Citation Analysis]
4 Abrantes AM, Pires AS, Monteiro L, Teixo R, Neves AR, Tavares NT, Marques IA, Botelho MF. Tumour functional imaging by PET. Biochim Biophys Acta Mol Basis Dis 2020;1866:165717. [PMID: 32035103 DOI: 10.1016/j.bbadis.2020.165717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Jamtani I, Lee KW, Choi Y, Choi Y, Lee JM, Han ES, Hong K, Choi GS, Kim JM, Yi NJ, Hong SK, Byun J, Hong SY, Suh S, Joh JW, Suh KS. Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma. J Clin Med 2021;10:2869. [PMID: 34203396 DOI: 10.3390/jcm10132869] [Reference Citation Analysis]
6 Çelebi F, Yaghouti K, Cindil E, Dogusoy GB, Tokat Y, Balcı C. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms. Acad Radiol 2021;28:189-98. [PMID: 32111468 DOI: 10.1016/j.acra.2020.01.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hu Y, Liu G, Yu H, Gu J, Shi H. Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT. Eur J Nucl Med Mol Imaging 2022. [PMID: 35344063 DOI: 10.1007/s00259-022-05772-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang J, Shao Y, Liu B, Wang X, Geist BK, Li X, Li F, Zhao H, Hacker M, Ding H, Zhang H, Huo L. Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function. BMC Med Imaging 2021;21:90. [PMID: 34034664 DOI: 10.1186/s12880-021-00623-2] [Reference Citation Analysis]
9 Min JH, Kim SH, Hwang JA, Hyun SH, Ha SY, Choi SY, Kim SW, Kim HS. Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas. Eur Radiol 2021;31:3649-60. [PMID: 33211142 DOI: 10.1007/s00330-020-07378-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Honka M, Rebelos E, Malaspina S, Nuutila P. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer. Metabolites 2022;12:321. [DOI: 10.3390/metabo12040321] [Reference Citation Analysis]
11 Vibert E, Schwartz M, Olthoff KM. Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol. 2020;72:262-276. [PMID: 31954491 DOI: 10.1016/j.jhep.2019.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
12 Shi X, Xing H, Yang X, Li F, Yao S, Congwei J, Zhao H, Hacker M, Huo L, Li X. Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study. Eur J Nucl Med Mol Imaging 2021;48:1593-603. [PMID: 33097975 DOI: 10.1007/s00259-020-05070-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
13 Sabaté-Llobera A, Mestres-Martí J, Reynés-Llompart G, Lladó L, Mils K, Serrano T, Cortés-Romera M, Bertran E, Fabregat I, Ramos E. 2-[18F]FDG PET/CT as a Predictor of Microvascular Invasion and High Histological Grade in Patients with Hepatocellular Carcinoma. Cancers (Basel) 2021;13:2554. [PMID: 34070953 DOI: 10.3390/cancers13112554] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Miao W, Nie P, Yang G, Wang Y, Yan L, Zhao Y, Yu T, Yu M, Wu F, Rao W, Wang Z. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation. Eur J Nucl Med Mol Imaging 2021. [PMID: 33813592 DOI: 10.1007/s00259-021-05328-w] [Reference Citation Analysis]
15 Howard BA, Wong TZ. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiol Clin North Am 2021;59:737-53. [PMID: 34392916 DOI: 10.1016/j.rcl.2021.06.001] [Reference Citation Analysis]
16 Damuka N, Dodda M, Solingapuram Sai KK. PET Use in Cancer Diagnosis, Treatment, and Prognosis. Methods Mol Biol 2022;2413:23-35. [PMID: 35044651 DOI: 10.1007/978-1-0716-1896-7_4] [Reference Citation Analysis]
17 Ida Y, Tamai H, Shingaki N, Shimizu R, Maeshima S, Maekita T, Iguchi M, Terada M, Kitano M. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation. Cancer Imaging 2020;20:74. [PMID: 33076990 DOI: 10.1186/s40644-020-00356-5] [Reference Citation Analysis]
18 Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P. Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus 2021;13:e19274. [PMID: 34754704 DOI: 10.7759/cureus.19274] [Reference Citation Analysis]